Multiple Myeloma in Relapse Completed Phase 1 / 2 Trials for Perifosine (DB06641)

IndicationStatusPhase
DBCOND0036092 (Multiple Myeloma in Relapse)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00401011Safety & Efficacy Study of Perifosine + Bortezomib +/- Dexamethasone for Multiple Myeloma PatientsTreatment